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Abstract—Aims:Inthisstudywedeterminedwhetherafolicacid-supplementeddietcouldchangehyperlipaemiaprovokedbychronic
ethanol intake in adult and pup rats. Methods: Animals were randomized into eight groups (four adults and four pups): control groups,
water and basic diet; alcohol groups, 20% ethanol and basic diet; alcohol folic acid groups, 20% ethanol and diet supplemented with
folic acid; control folic acid groups, water and folic acid-supplemented diet. We determined serum and liver total cholesterol (Chol),
HDL, triglycerides (TG), phospholipids (PL) and bile acids (BA) levels in all of the groups. Hydroxymethylglutaryl-CoA (HMG-CoA)
reductase activity was also measured in the livers. Results: Ethanol-fed rats have higher serum HDL and PL levels in pups and higher
serum LDL, TG and PL levels in adults than controls and supplemented animals with or without alcohol ingestion. Ethanol provokes an
increase in hepatic Chol and BA, and a decrease in hepatic TG and PL in pups; in adults it also provokes an increase in hepatic Chol and
BA and a significant increase in HMG-CoA reductase activity. Alcohol intake plus folic acid supplementation has no effects on these
values except BA levels that were significantly higher, in both pups and adult rats, than in the control group. Conclusion: Despite the
fact that alcohol intake provokes different lipid alterations in adults and in pups whose mothers drank ethanol, folic acid contributes to
the alleviation of these adverse effects reducing HMG-CoA reductase activity in adult rats and, except BA levels, to normalizing lipids
values due to the fact that folic acid acts as a choleretic compound. We can therefore assume that folic acid supplementation reduces
alcohol-induced hypercholesterolaemia by decreasing synthesis and increasing catabolism.
INTRODUCTION
Lipid homeostasis is altered by chronic ethanol consumption
leading to the development of a fatty liver as well as lipid al-
terations in other organs (Carrasco et al., 2002). The plasma
triglyceride (TG) levels of alcoholic patients have been corre-
lated with alcohol consumption (Baraona and Lieber, 1998).
Pennington et al. (2002) reported an increase in fasting serum
TG levels in rats whose mothers consumed ethanol. Hyper-
triglyceridaemia has been identified as an independent riskfac-
tor for cardiovascular disease (CVD) (Walldius and Jungner,
2006).
Alcohol-consumption-associated hyperlipidaemia is also
relevant to CVD. In drinking populations, elevations in LDL
cholesterol arecorrelated withCVDrisk;however, increases in
HDL cholesterol are associated with protection (Walldius and
Jungner,2006).Intheadultpopulation, alcoholconsumptionis
independentlyanddirectlyassociatedwithcirculatingoxidized
LDL (Schroder et al., 2006). Independently of the total choles-
terol level (Chol), accumulating evidence suggests that certain
lipid oxidation products, such as oxidized phospholipids (PL),
may represent endogenously formed factors capable of trigger-
ing the vascular inflammation responsible for atherosclerosis
(Walldius and Jungner, 2005; Leitinger, 2005).
Chronic alcoholism disturbs folate homeostasis (Fernandez-
Borrachero et al., 1996), because it alters intestinal absorption,
hepatic uptake and the renal conservation of folates, affecting
the functional expression of folate transports in relevant tissue
membranes: the jejunal brush border, the liver plasma mem-
brane and the kidney brush border membrane (Hamid et al.,
2007a, 2007b; Hamid and Kaur, 2007), even in suckling rats
(Murillo-Fuentes et al., 2007).
Folic acid is recognized as possibly being an important el-
ement in the prevention of CVD. To date, most studies have
focused on the homocysteine-lowering effect of folate; a sup-
plementation with folic acid reduces serum homocysteine lev-
els and in vitro LDL oxidation in patients with coronary artery
disease (Bunout et al., 2000).
Inendothelialcells,5-methyltetrahydrofolate(5-MTHF),the
active form of folic acid, has intrinsic antioxidant actions such
as a reduction in superoxide anion production (Stroes et al.,
2000) and it also reduces the human umbilical vein endothelial
cells that induce LDL oxidation (Ronco et al., 2005). Ronco
et al. (2007) have also shown for the first time that there is a
specific mechanism between 5-MTHF and LDL that regulates
endothelial function. Carnicer et al. (2007) have found that the
administration of folic acid decreased atherosclerotic lesions
independently of plasma homocysteine and cholesterol levels;
it was associated with plasma levels of apolipoproteins A-I,
A-IV and B, and decreased oxidative stress.
Folate deficiency might also contribute to atherosclerosis
and vascular injury by modifying fatty acid metabolism in folic
acid-deficient rats; Durand et al. (1996) have reported signifi-
cant changes in the fatty acid composition.
Folic acid plays an important and recognized role in preg-
nant rats; alcohol consumption during pregnancy and lactation
decreases milk and serum folate levels in both mothers and
their pups (Garc´ ıa-Rodriguez et al., 2003; Tavares et al., 2000;
Murillo-Fuentes et al., 2003). However, we did not find any
studies on the effects of folic acid on lipid metabolism in adults
and their offspring. Therefore, the present study was designed
to study:
1. The effects of chronic alcohol consumption on serum and
hepatic lipid levels, and whether administering folic acid
to chronic alcohol-fed rats might contribute to preventing
adverse ethanol-induced effects in the lipid metabolism of
adults and pups.
2. The action of alcohol consumption and of folic acid upon
cholesterol synthesis by measuring HMG-CoA reductase
C   The Author 2008. Published by Oxford University Press on behalf of the Medical Council on Alcohol. All rights reserved
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activity—the enzyme that limits Chol synthesis—and its
action upon cholesterol catabolism by measuring bile acids
(BA), whose task is to eliminate cholesterol.
EXPERIMENTAL PROCEDURES
Animals
Male and female Wistar rats (Centro de Producci´ on y Experi-
mentaci´ on Animal, Vicerrectorado de Investigaci´ on, Universi-
dad de Sevilla), weighing ∼150–200 g, were randomized into
four groups: control (C), alcohol (A), alcohol + folic acid (AF)
and control + folic acid (CF). Drinking water (with or without
ethanol) and diet (supplemented or not) were given ad libi-
tum during 8 weeks. Male (n = 6) and female (n = 6) rats
were mated to obtain the first generation offspring for each
group. After reproduction, the male rats were divided into four
groups of six and used as adult male groups. Pregnant rats were
housed individually in plastic cages, and continued with their
alcoholic treatment. The day of parturition was designated as
Day 1 of lactation, the number of offspring being reduced to
10 per mother at parturition, and Day 21 as the final day of
the lactation period. The experiments were performed on the
offspring of all four groups 21 days postpartum (CO: control
group; AO: ethanol group; AFO: ethanol folic acid group and
CFO: control folic group) and in the four groups of male adult
rats after 8 weeks of treatment (C, A, AF, CF). Due to their
hormonal disorders, the adult female rats were not considered.
The animals were kept at an automatically controlled tem-
perature (22–23◦C) and a 12-h light–dark cycle (9:00 to
21:00 hours). Animal care complied with the Guide for the
CareandUseofLaboratoryAnimals(NationalAcademyPress,
Washington, DC, 1996).
Ethanol treatment
Ethanol treatment has been described previously by our group
(F´ ernandez-Borracheroetal.,1998).Alcohol-fedadultanimals
were started on tap water containing 5% v/v alcohol in the first
week (initial time). The alcohol concentration was increased to
10% in the second week, 15% in the third week and 20% in the
fourth week; this solution was maintained for 4 weeks. Male
rats finished their treatment after reproduction (8 weeks). Preg-
nant females were placed in individual cages and were again
assigned 20% ethanol in drinking water as the sole source of
liquid with food ad libitum during pregnancy and lactation
(Figure 1). Both the diet and the ethanol solution were pro-
vided ad libitum. Ethanol intake (g/kg body weight/day) was
calculated as previously described by Veale and Myers (1968).
Diets
ThedietswerepreparedaccordingtotheCounciloftheInstitute
of Laboratory Animal Resources (ILAR, 1979) (g/kg of diet):
casein,200;glasssucrose,510;cornstarch,140;fibre,cellulose,
50; corn oil, 50; AIN-76 mineral mix, 35; AIN-76 vitamin mix,
10;cholinebitartrate,2;DL-methionine,3.Thedietingredients
were mixed and homogenized in a double-cone blender (Rest,
Haan, Germany). The supplemented diet contained 8 ppm folic
acid(Acofarma)versusthecontroldietwhichcontained2ppm.
The diets were monitored by previously weighing the amount
of food and weighing it again at the end of every week.
Fig. 1. Alcohol treatment schedule. Alcohol-fed adult animals were started on
tapwatercontaining5%v/valcoholinthefirstweek,thealcoholconcentration
was increased to 10% in the second week, 15% in the third week and 20% in
the fourth week (this solution was maintained for 4 weeks). Male rats finished
their treatment after reproduction. Pregnant female rats were again assigned
20% ethanol in drinking water for another 6 weeks.
Ethanol and lipid intakes measurements
The amount of ethanol consumed was estimated by subtracting
the initial volume provided in the bottle at the beginning of the
week, from the volume at the end of the week. We have done it
during all the experimental procedure. Lipid consumption was
measured by weighing the initial amount of food and weighing
it again at the end of every week. Diet lipid composition is
known.
Samples
At the end of the experimental period, the rats were fasted for
24 h and anaesthetized with intraperitoneal urethane 28% v/v
(0.5 ml/100 g of body weight). The abdomen was opened by
a midline incision and whole livers were removed, debrided of
adipose and connective tissue in ice-cold saline and weighed.
Samples were immediately stored at −80◦C prior to biochemi-
cal determinations. Blood was collected by heart puncture and
then centrifuged.
Analysis
Serum ethanol was determined by a commercial enzymatic-
colorimetric test (Sigma) according to the technique described
by Bucher and Redetzki (1951) with alcohol dehydrogenase
(ADH), at a wavelength of 340 nm. Serum folate levels were
obtained by means of a Waxman and Schreiber radio assay
kit (1980). TGs were determined by an enzymatic procedure
described by Young and Pestaner (1975). HDL cholesterol
was determined using the method described by Grove (1979).
LDL and VLDL-cholesterol was evaluated using Friedewald’s
formula (Friedewald et al. 1972). The LDL/HDL ratio was
calculated as a ratio between the LDL and HDL values ob-
tained by the cited methods. Total serum and liver cholesterol
were determined by an enzymatic procedure based on the oxi-
dase/peroxidase cholesterol method with commercial kits from
Attom(Allain,1974;Svensson,1982).SerumandliverPLwere
determined by an enzymatic-colorimetric technique (Trinder,
1969; Takeyama et al., 1977). Bile acid in the serum and liver
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 546 Ojeda et al.
was determined by using an enzymatic procedure with com-
mercial kits (Sigma Diagnostic) (Svensson, 1982; Roda et al.,
1982).
Preparation of hepatic microsomes
The microsome preparation involved the livers being excised,
weighed and washed in an ice-cold homogenization medium.
All subsequent operations were carried out at 4◦C. The liv-
ers were homogenized in a Potter-Elvehjem homogenizer with
an ice-cold homogenization medium containing 0.25 M NaCl,
50 mM imidazol (pH 7.4), 20 mM ethylenediamine tetra-acetic
acid (EDTA), 5 mM DTT and 50 mM NaF. In the presence
of NaF (a dephosphorylation inhibitor), the measured activity
of the enzyme reflected the activity that was present initially
in the tissue (active form). Each homogenate was centrifuged
in a Beckman centrifuge J2–21 class, JA-17 rotor to remove
particulate matter, for 20 min at 15,000 g. The supernatant was
collected and the centrifugation (15,000) was repeated. The
15,000 g supernatant was centrifuged at 105,000 g for 60 min
in a Sorvall ultracentrifuge, model OTD 50 B. The resulting
microsomal pellets were immediately frozen in liquid N2 and
stored at −80◦C until assaying. The storage time did not result
in a significant loss of enzyme activity (results not shown).
HMG-CoA reductase activity was measured as described by
Shapiro et al. (1974) with slight modifications by Molina et al.
(1997). This method measures the formation of radioactive
mevalonate from labelled HMG-CoA reductase. One hundred
microlitres of pre-incubated medium containing 0.2–0.4 mg
mucosal protein, in addition to the components present in the
homogenization medium, was incubated at 37◦C for 15 min.
Then, 50 µl of solution containing 0.25 M NaCl, 50 mM imi-
dazol (pH 7.4), 20 mM EDTA, 5 mM DTT, 110 mM glucose-
6-phosphate dehydrogenase and 1 mM DL-3-14C-HMG-CoA
reductase (specific activity 4000–8000 dpm/nmol) was added
to the pre-incubated mixture and then incubated for 30 min at
37◦C. The reaction was stopped by adding 25 µlo f5NH C l .
The 14Cmevalonateformedwasconvertedintothelabelledlac-
tone, isolated by thin-layered chromatography and counted by
liquid scintillation using an internal standard of 3H-mevalonate
to correct for incomplete recovery.
Statistical analyses
The results are expressed as a mean ± SEM. The data were
analysed using a statistical program (GraphPad InStat 3) by
analysing the ANOVA parametric variance test followed by
Tukey–Kramer tests. A P value of <0.05 was considered to be
statistically significant.
RESULTS
As Table 1 shows, the lipid intake in adult male rats was sig-
nificantly lower in groups treated with ethanol (A, AF), than
in the control groups (C, CF) throughout the whole experimen-
tal period (8 weeks). This decrease was especially significant
between the fifth and eight weeks of treatment, when alcohol
concentration was 20%. The supplementation with folic acid
did not alter the lipid intake.
The ethanol-fed dams’ offspring’s birth weight and body
weight at 21 days postpartum (AO) were lower than control
group (CO), control folic group (CFO) and alcohol folic group
(AFO) (Table 2).
In Table 3, ethanol intake and serum ethanol levels were
similar in the A and AF groups. Folic acid intake and serum
folate levels were significantly lower in ethanol rats (A) than
in the rest of the groups. In the folic acid supplement groups
(AFandCF)higherserumfolateconcentrationswereobserved,
confirming that the supplementation was effective. However,
the groups treated with ethanol (A, AF) presented lower serum
folatelevelsthancontrolwithorwithoutfolatesupplementation
(C, CF).
Ethanol adult fed rats (A) had higher serum TG levels than
controls and supplemented animals with or without alcohol
ingestion (Table 4). However,there were no significant differ-
ences in hepatic TG levels among the experimental groups
(Table 6). Serum TG levels in pups did not present differences
between the groups (Table 5). Hepatic pups’ TG levels were
significantly lower when their mothers were treated with al-
cohol; however, alcohol intake plus folic acid supplementation
has no effect on these values (Table 7). Serum TG levels were
significantly higher in adult rats (P < 0.001).
We did not find differences in serum Chol between adult
groups. However, chronic alcohol consumption resulted in
higher serum LDL and VLDL and lower HDL, and therefore
the LDL/HDL ratio was higher in A (Table 4). Ethanol-fed rats
supplemented with folic acid had no differences to the con-
trol group. Curiously, the results in pups were different: only
HDL serum levels presented differences between the groups,
and in this case HDL was significantly higher in AO, pre-
senting a better LDL/HDL ratio than in the rest of the groups
(Table 5). Ethanol folic acid-supplemented rats have similar
values to control levels. Serum HDL levels in AO pups were
significantly higher than in A adults. Serum LDL in control
pups (CO and CFO) were higher than those in adults (P <
0.001); however, serum VLDL values were higher in adults
(P < 0.001).
HepaticCholvaluesinbothethanolgroups(AandAO)were
significantly higher than controls groups. However, alcohol
intake plus folic acid supplementation had no effect on these
values (Tables 6 and 7).
HMG-CoA reductase activity was similar in all pup groups
(Table 7), but was higher in A adults than the others adult
groups (Table 6). Ethanol-treated adult rats supplemented with
folic acid (AF) had similar levels to control rats. Adult A rats
showed higher values of hepatic HMG-CoA reductase activity
than pups (AO).
Both in pups and in adult ethanol rats (A, AO), serum PL
presented higher levels (Tables 4 and 5) than control and sup-
plementedanimalswithorwithoutalcoholingestion.However,
despite the hepatic PL, the values did not present differences
between groups in adults (Table 6). AO pups had lower hepatic
PL; however, AFO animals had similar values to control group
(CO) (Table 7). Hepatic PL levels were significantly higher in
pups (P < 0.001); however, serum PL was only higher in AO
pups with respect to the adults (A) (P < 0.001).
SerumBAvalues didnotshow differences between theeight
experimental groups (Tables 4 and 5). In both pups and adults,
hepatic BA levels were higher in ethanol groups with respect
to control and control folic groups; however, AF showed the
highest BA hepatic levels (Tables 6 and 7). Hepatic BA in A
and AF adults was higher than in pups (P < 0.001).
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Table 1. Lipids male adult rats intake (g/rat/day) during the whole experimental period from the first to the eighth week of treatment
First week Second week Third week Fourth week Fifth week Sixth week Seventh week Eighth week
C( n=6) 1.2 ± 0.05 1 ± 0.02 1 ± 0.04 1.1 ± 0.01 1.1 ± 0.02 1.1 ± 0.03 1.2 ± 0.03 1 ± 0.04
A( n=6) 1 ± 0.03∗∗∗,aa 1 ± 0.04∗∗,a,bb 0.7 ± 0.03∗∗∗,aaa 0.7 ± 0.03∗∗∗,aaa,b 0.5 ± 0.03∗∗∗,aaa 0.5 ± 0.03∗∗∗,aaa 0.6 ± 0.06∗∗∗,aaa 0.6 ± 0.02∗∗∗,aaa
AF (n=6) 1 ± 0.02ccc,dd 0.8 ± 0.04cc,ddd 0.8 ± 0.02ccc,ddd 0.6 ± 0.02ccc,ddd 0.5 ± 0.03ccc,ddd 0.4 ± 0.03ccc,ddd 0.5 ± 0.03ccc,ddd 0.6 ± 0.03ccc,ddd
CF (n=6) 1.2 ± 0.03 1.15 ± 0.04 1.15 ± 0.03ee 1.2 ± 0.03e 1.15 ± 0.04 1.1 ± 0.04 1.12 ± 0.03 1.1 ± 0.03
The results are expressed as mean ± SEM and analysed by a multifactorial analysis of variance (ANOVA) followed by Tukey’s test. n indicates the number of
animals in each group. Groups: C, control group; A, alcohol group; AF, alcohol folic acid group; CF, control folic acid group. Signification: A versus C, ∗∗∗P <
0.001, ∗∗P < 0.01; A versus CF, aaaP < 0.001, aaP < 0.01, aP < 0.05; A versus AF, bbP < 0.01, bP < 0.05; AF versus C, cccP < 0.001, ccP < 0.01; AF versus
CF, dddP < 0.001, ddP < 0.01; CF versus C, eeP < 0.01, eP < 0.05.
Table 2. Birth weight and body weight of the offspring at day 21 postpartum (g)
CO (n=10) AO (n=10) AFO (n=10) CFO (n=10)
Birth weight (g) 6.71 ± 0.07 5.9 ± 0.2∗∗,aa,bb 6.5 ± 0.08 6.65 ± 0.08
Body weight at 21-day postpartum (g) 36.2 ± 0.6 19.3 ± 0.9∗∗∗,aaa,bbb 29.6 ± 0.7ccc,ddd 34.6 ± 0.7
The results are expressed as mean ± SEM and analysed by a multifactorial analysis of variance (ANOVA) followed by Tukey’s test. n indicates the number of
animals in each group. Groups: CO, control group; AO, alcohol group; AFO, alcohol folic acid group; CFO, control folic acid group. Signification: AO versus
CO, ∗∗∗P < 0.001, ∗∗P < 0.01; AO versus CFO, aaaP < 0.001, aaP < 0.01; AO versus AFO, bbbP < 0.001, bbP < 0.01; AFO versus CO, cccP < 0.001; AFO
versus CFO, dddP < 0.001.
Table 3. Effects of ethanol and folic acid treatment on ethanol and folic acid intake and serum ethanol and folic acid in male adult rats
C( n=6) A (n=6) AF (n=6) CF (n=6)
Ethanol intake (g/kg b.w./day) – 15.9 ± 1.4 16.7 ± 1.7 –
Folate intake (µg/rat/day) 38.67 ± 1.53 22.48 ± 0.95∗∗,aaa,bbb 103.34 ± 4.23ccc,ddd 178.6 ± 4.35eee
Serum ethanol (mg/dl) – 60.03 ± 22.2 57.17 ± 11.4 –
Serum folate (ng/ml) 11.5 ± 0.2 7.31 ± 02∗∗∗,aaa,bbb 21.2 ± 0.6ccc,ddd 32.48 ± 0.9eee
The results are expressed as mean ± SEM and analysed by a multifactorial analysis of variance (ANOVA) followed by the Tukey’s test. n indicates the number of
animals in each group. Groups: C, control group; A, alcohol group; AF, alcohol folic acid group; CF, control folic acid group. Signification: A versus C, ∗∗∗P <
0.001, ∗∗P < 0.01; A versus CF, aaaP < 0.001; A versus AF, bbbP < 0.001; AF versus C, cccP < 0.001; AF versus CF, dddP < 0.001; CF versus C, eeeP < 0.001.
Table 4. Serum lipid values in male adult rats
Adult rats serum values C (n=6) A (n=6) AF (n=6) CF (n=6)
Chol (mg/dl) 96.7 ± 8.7 112.17 ± 9.5 111.95 ± 9.5 94.78 ± 8.3
HDL (mg/dl) 37.8 ± 2.62 22.65 ± 1.05∗∗∗ 43.89 ± 2.73bbb 40.08 ± 2.3aaa
LDL (mg/dl) 46.74 ± 1.7 66.9 ± 4.41∗∗ 52.56 ± 4.38 44.86 ± 2.3aa
VLDL (mg/dl) 12.1 ± 1.05 23.14 ± 1.86∗∗∗ 15.5 ± 1.48bb 9.84 ± 2.3aaa,c
LDL/HDL 1.23 ± 0.15 2.9 ± 0.26∗∗∗ 1.19 ± 0.13bbb 1.11 ± 0.12 aaa
TG (mg/dl) 60.7 ± 5.25 105.7 ± 9.22∗∗∗ 77.94 ± 7.45b 49.2 ± 3.2aaa,c
PL (mg/dl) 104 ± 13.08 147 ± 9.5∗ 134 ± 7.68 101 ± 13.08a
BA (mmol/l) 37.7 ± 5.6 32.9 ± 3.7 26.2 ± 2.6 33.7 ± 4.6
The results are expressed as mean ± SEM and analysed by a multifactorial analysis of variance (ANOVA) followed by Tukey’s test. n indicates the number of
animals in each group. Groups: C, control group; A, alcohol group; AF, alcohol folic acid group; CF, control folic acid group. Signification: A versus C, ∗∗∗P <
0.001, ∗∗P < 0.01, ∗P < 0.05; A versus CF, aaaP < 0.001, aaP < 0.01, aP < 0.05; A versus AF, bbbP < 0.001, bbP < 0.01, bP < 0.05; AF versus CF, cP < 0.05.
Table 5. Serum lipid values in offspring rats
Offsprings serum values CO (n=10) AO (n=10) AFO (n=10) CFO (n=10)
Chol (mg/dl) 121.7 ± 13.89 131.7 ± 10.77 102.7 ± 14.3 113.7 ± 10.89
HDL (mg/dl) 38.28 ± 2.1 58.64 ± 4.3∗∗∗ 36.63 ± 3bbb 35.28 ± 1.9aaa
LDL (mg/dl) 77.9 ± 6.2 66.25 ± 5.7 60.6 ± 6.2 72.9 ± 5.9
VLDL (mg/dl) 5.58 ± 0.45 6.22 ± 0.59 5.5 ± 0.43 5.53 ± 0.48
LDL/HDL 2.02 ± 0.2 1.13 ± 0.11∗∗ 1.65 ± 0.17b 2.06 ± 0.18 aa
TG (mg/dl) 27.93 ± 2.28 31.11 ± 3.13 27.5 ± 2.46 27.65 ± 2.3
PL (mg/dl) 156.1 ± 6.7 273.8 ± 27∗∗∗ 154.5 ± 15bbb 155.6 ± 8.7aaa
BA (mmol/l) 40.3 ± 1.89 44.17 ± 3.4 34.8 ± 3.4 38.3 ± 2.89
The results are expressed as mean ± SEM and analysed by a multifactorial analysis of variance (ANOVA) followed by the Tukey’s test. n indicates the number
of animals in each group. Groups: CO, control group; AO, alcohol group; AFO, alcohol folic acid group; CFO, control folic acid group. Signification: AOv e r s u s
CO, ∗∗∗P < 0.001, ∗∗P < 0.01; AO versus CFO, aaaP < 0.001, aaP < 0.01; AO versus AFO, bbbP < 0.001, bP < 0.05.
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Table 6. Hepatic lipid values and HMGCoA reductase activity in male adult rats
Adult rats hepatic values C (n=6) A (n=6) AF (n=6) CF (n=6)
HMG-CoA reductase activity (nmol/mg/min) 92.3 ± 6.9 148.3 ± 16.8∗∗∗ 137.9 ± 12.3b 90.6 ± 5.7aaa
Chol (mg) 17.24 ± 1.8 31.8 ± 3.4∗∗∗ 14.9 ± 0.9bbb 15.8 ± 1.2aaa
PL (mg) 63 ± 4.2 59 ± 3.9 55 ± 3.8 61 ± 4.7
TG (mg) 113.96 ± 7.05 96.20 ± 9.14 84.7 ± 8.44 109.6 ± 9.05
BA (µmol/g) 1.96 ± 0.4 5.4 ± 0.55∗∗ 8 ± 0.9b,cc 2.13 ± 0.22aa,dd
The results are expressed as mean ± SEM and analysed by a multifactorial analysis of variance (ANOVA) followed by Tukey’s test. n indicates the number of
animals in each group. Groups: C, control group; A, alcohol group; AF, alcohol folic acid group; CF, control folic acid group. Signification: A versus C, ∗∗∗P <
0.001, ∗∗P < 0.01; A versus CF, aaaP < 0.001, aaP < 0.01; A versus AF, bbbP < 0.001, bP < 0.05; AF versus C, ccP < 0.01; AF versus CF, ddP < 0.01.
Table 7. Hepatic lipid values and HMGCoA reductase activity in offspring rats
Offsprings hepatic values CO (n=10) AO (n=10) AFO (n=10) CFO (n=10)
HMG-CoA reductase activity (nmol/mg/min) 78.38 ± 5.37 80.18 ± 9.87 73.45 ± 4.68 77.45 ± 6.7
Chol (mg) 21.49 ± 0.98 40.75 ± 3.75∗∗∗ 23.69 ± 1.95bbb 20.18 ± 1.2aaa
PL (mg) 141.11 ± 6.21 108.46 ± 6.73∗∗ 151.20 ± 7.5bbb 143.2 ± 5.21aaa
TG (mg) 148.9 ± 12.44 76.31 ± 10.5∗∗∗ 104.7 ± 11.29 143.2 ± 13.5aaa
BA (µmol/g) 0.67 ± 0.07 1.19 ± 0.12∗ 1.51 ± 0.14bbb 0.75 ± 0.06a
The results are expressed as mean ± SEM and analysed by a multifactorial analysis of variance (ANOVA) followed by Tukey’s test. n indicates the number of
animals in each group. Groups: CO, control group; AO, alcohol group; AFO, alcohol folic acid group; CFO, control folic acid group. Signification: AO versus
CO, ∗∗∗P < 0.001, ∗∗P < 0.01, ∗P < 0.05; AO versus CFO, aaaP < 0.001, aP < 0.05; AO versus AFO, bbbP < 0.001.
DISCUSSION
The principal finding of this study was that folic acid, a po-
tential antioxidant nutrient (Durand et al., 1996), could be an
associated treatment for lipid homeostasis alteration provoked
by chronic ethanol consumption and could prevent CVD risk
in adults and even in pups whose mothers drank alcohol during
pregnancy and lactation. This action is clear when we supple-
ment alcoholic pregnant rats with folic acid; in this case their
pups’ weights at birth are similar to control and higher than
ethanol pups’; this effect of supplementation is not so great
during lactation.
Following Pennington et al. (2002), who defended that ma-
ternal dietary ethanol consumption is associated with hyper-
triglyceridaemia in adult rat offspring, we have not found dif-
ferences in TG pups levels, but we have found an increase
in serum TG levels in adult A rats, despite a decrease of
lipid intake in the alcohol group during the experimental pe-
riod. Pups showed a significant decrease in hepatic TG levels
when they were treated with alcohol; this fact might be due
to the low-serum-TG concentrations in normal pups due to
their diet (Okada et al., 2002) and the poor TG level reg-
ulation shown at this early age. In any case, ethanol folic
acid-supplemented pups had similar hepatic TG values to
controls, and AF adult rats had similar serum TG levels to
controls.
Brand-Herrmann et al. (2005) have found a genetic asso-
ciation in humans between alcohol and HDL. It appears that
alcohol intake modulates the relationship between the peroxi-
some proliferator-activated receptor δ (a receptor that can af-
fect plasma lipids) and HDL. This alteration in plasma lipids
was also found in several studies with chronic alcoholics and
ethanol adult rats (Kwon et al., 2005; Maneesh and Jayalek-
shmi, 2005; Choi et al., 2006). In line with these studies, our
results showed a significant increment in serum VLDL and
LDL, and a decrease in HDL levels in A adult rats; these val-
ues imply a significant increased risk for CVD (Walldius and
Jungner, 2006).
Seekingnewstrategiesagainstalcoholism,Lee(2004)found
that Pueraria radix, a traditional oriental medicinal plant, could
diminish plasma Chol in ethanol-treated rats; Maneesh and
Jayalekshmi (2005) also found that exogenous ascorbic acid,
alpha-tocopherol and other antioxidants exhibited an ability
to counteract the alcohol-induced changes in lipid parameters.
Kwon et al. (2005) reported the effects of traditional Chinese
medicineonalcohol-inducedfattyliversinrats,concludingthat
this treatment reduced plasma TG and Chol. Taking our data as
our point of departure, we can report that folic acid supplemen-
tation in ethanol adult rats improves the serum lipid profile of
these animals, diminishing TG, VLDL and LDL serum and in-
creasing HDL levels. Folic acid intake in chronic ethanol adult
rats therefore significantly reduced the LDL/HDL cholesterol
ratio, probably due to changes in the HDL-cholesterol concen-
tration. These effects of folic acid are similar to those studied
byMayeretal.(2006)inhypercholesterolaemichumans:folate
co-administratedwithfenofibratewasfollowedbyasignificant
decrease in plasma LDL and oxidized LDL.
From the limited literature available, it would appear that
the biological variability of serum lipid parameters in children
is similar to that reported for adults (Tolfrey, 2002). How-
ever, the studies that have focused on this issue are scarce, so
Kwiterovichetal.(2004)determinedthatthegestationalagein
humans has a significant effect on both LDL and HDL. Bastida
etal.(2002)suggestedthatwhenChollevelsarehighinhumans
atbirth,thisismainlyduetoanincreaseinLDL.Surprisingly,in
ourpupratslipoproteinresultsweredifferent;onlyserumHDL
presented differences between the groups, and in this case
HDL was significantly higher in AO, presenting a better
LDL/HDL ratio than the rest of the groups. It appears that
chronic alcohol consumption by the pups’ mothers could have
a protective effect on the pups’ lipid metabolism. This is not
exactly the case, however: it must be borne in mind that in
their normal status, offspring (CO and CFO) showed signif-
icantly higher LDL serum values than adults and a trend of
higher serum Chol levels and therefore the basal status in pups
is different to that of adults. LDL did not increase in AO pups,
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and VLDL is lower than that in adults, so the only lipoprotein
that could increase was HDL. Moreover, PL levels (higher in
pups) are the principal components of HDL. Furthermore, it
is important to remember that there is great intra-individual
variation in children’s lipid-lipoprotein profiles (Cabrera et al.,
1996; Tolfrey, 2002).
Serum PL (a new atherogenix risk factor (Zhang and
Salomon, 2005)) presented higher levels in ethanol groups.
Folic acid diminished PL values, showing its action against
CVD risk factors. Pups presented higher values of serum PL in
AO and hepatic PL in all of the groups, perhaps, because the
presence of these lipids in newborn pups is essential for their
development (Rump et al., 2001).
Despitethefactthatalcoholicadultsandpupsdidnotpresent
higher serum Chol values, they did present higher Chol hep-
atic values, yet increased HMG-CoA reductase activity was
only present in adults. Hepatic BA values increased in ethanol
groups, increasing Chol catabolism, so it seems to be an effec-
tive mechanism to control serum Chol. However, HMG-CoA
did not increase in AO offspring. This might be because AO
presented high serum HDL levels that return Chol to the liver,
and because hepatic BA in offspring was significantly lower
than that in adults despite similar or slightly higher hepatic
Chol levels.
Curiously, hepatic BA presented a significant increase in
ethanol with respect to control and control-folic groups and
when rats were supplemented with folic acid these values were
even higher. These values are in concordance with other stud-
ies that present folinic acid as a good choleretic treatment
(Kajiyama et al., 1998). Perhaps, because of this possible
choleretic action, folic acid contributes to improving ethanol
rats’ serum and hepatic Chol. However, serum BA levels were
similar between adult and pup groups, perhaps BA are being
eliminated in the faeces.
Our findings suggest that supplementary folic acid only ben-
efitsindividualswithlow-plasma-folateconcentration(chronic
ethanoltreatment),asoccurswithotherfolateactions(Martinez
et al., 2006) due to the fact that control values were similar to
the control-folic values in all of the experiments.
Theproposedmechanismoffolicacidonlipidmetabolismis
that it acts indirectly, reducing the homocystein levels that are
elevated during ethanol consumption (Bayerlein et al., 2005),
and by a specific mechanism between 5-MTHF and LDL that
regulateendothelialfunctionsreducingoxidizedLDL,thusim-
proving lipid metabolism in ethanol-treated rats. This effect is
more pronounced in the adult population, where alcohol con-
sumption was independently and directly associated with cir-
culating oxidized LDL (Schroder et al., 2006).
Insummary,ethanolintakeprovokeslipidalterationsinadult
rats and in those offspring rats whose mothers drank ethanol,
but it affects them in a different manner. Ethanol alters serum
PL and HDL in offspring, and serum TG and lipoproteins in
adults. This is not unusual because these parameters are sig-
nificantly different in basal status (except HDL). Ethanol alters
hepaticChol,BA,TGandPLinpups,andChol,BAandHMG-
CoA reductase activity in adults. In the basal status, only PL
values were significantly different in adults and pups. In all
of these cases, folic acid contributes to alleviating the adverse
effect of ethanol ingestion by decreasing HMG-CoA reduc-
tase activity and by restoring lipid values, except BA levels.
This fact demonstrates that folic acid has a choleretic action.
We could therefore conclude that folic acid supplementation
reduces alcohol-induced hypercholesterolaemia by decreasing
synthesis(inadults)andincreasinglipidcatabolism,butfurther
evidence is necessary.
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